CPA
MLAB icon

Capital Performance Advisors’s Mesa Laboratories MLAB Stock Holding History

Capital Performance Advisors’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11
Closed -$1.43K – 1669
2024
Q3 		$1.43K Buy
+11
New +$1.29K ﹤0.01% 1731

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital Performance Advisors's MLAB Position: Q4 2024 in Review

Capital Performance Advisors sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 11 shares — an estimated $1.43K sold.

Capital Performance Advisors first reported a position in MLAB in Q3 2024 and held it in 1 quarter. The position peaked at $1.43K in Q3 2024. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

  • Capital Performance Advisors reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 11 Mesa Laboratories shares in Q4 2024, an estimated $1.43K.
  • Capital Performance Advisors first reported a position in Mesa Laboratories in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Mesa Laboratories position peaked at $1.43K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.